Drug Dealer Simulator publisher launches an investigation against Schedule 1 creator. The game is supposedly “violating company’s IP”
Drug Dealer Simulator publisher launches an investigation against Schedule 1 creator. The game is supposedly “violating company’s IP”

Drug Dealer Simulator publisher launches an investigation against Schedule 1 creator. The game is supposedly “violating company’s IP”
